Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
skilled in computational chemistry and data-driven approaches to develop new catalytic asymmetric reactions. World-leading industrial partners with a wide range of interests will provide advice on which
-
environmental and climate impact. Together with Dutch farmers, ReGeNL is a transdisciplinary program developing a future-proof agricultural sector in which agriculture goes hand in hand with soil health and
-
together academic research groups with expertise in experimental catalyst development and theoretical groups skilled in computational chemistry and data-driven approaches to develop new catalytic asymmetric
-
and inclusive environment in which everyone can flourish and contribute. To apply, please send your curriculum vitae, including a letter of motivation, via the ‘apply now’ button. Please also include a
-
package within the core research program of CropXR. Our goal is to develop computational methods to translate integrated simulation models of plant responses to stress (drought, heat) from a model plant
-
- Wageningen University & Research ) and Dr. Karen Kloth ( Karen Kloth - Wageningen University & Research ). Your project is part of the MiCRop Consortium programme on microbial imprinting of crop resilience
-
The PhD position is embedded in the research programme of Economics, Econometrics & Finance of FEB’s Research Institute. The project will be supervised by dr. J.A.M. de Grefte, prof. dr. B.P. de Bruin and
-
://research.wur.nl/en/persons/rieta-gols ) and Dr. Karen Kloth (https://research.wur.nl/en/persons/karen-kloth). Your project is embedded in the MiCRop Consortium programme on microbial imprinting of crop resilience
-
embedded in the MiCRop Consortium programme on microbial imprinting of crop resilience to (a)biotic stresses (https://www.microp.org). Within MiCRop, you will receive training and scientific exposure
-
completely inside the right ventricle. Precisely because of that, they would cause fewer complications in children than traditional pacemakers.' Karel Breeman, physician and researcher and Amsterdam UMC and